Treatment Options, Clinical Pathways, and Collaborative Care: A Multiple Myeloma Update for Managed Care and Specialty Pharmacy

You Are Invited to a Series of LIVE CME/CPE/CNE Webcasts!

Treatment Options, Clinical Pathways, and Collaborative Care: A Multiple Myeloma Update for Managed Care and Specialty Pharmacy Live Webcast

Live Webcast Dates
Wednesday, May 10, 2017 at 1:00 PM - 2:30 PM ET
Tuesday June 27, 2017 at 1:00 PM - 2:30 PM ET

Jointly provided by
Impact Education, LLC    
This activity is supported by independent educational grants from Celgene Corporation and Takeda Oncology.


Register Now

Once registered you will receive login information and reminders via email.

HOT TOPICS
  • Recent clinical data affecting evidence-based treatment guidelines for multiple myeloma (MM)
  • The value of clinical pathways initiatives as a means of reducing treatment variability and improving clinical and economic outcomes
  • Comprehensive care strategies involving effective communication methods
DISTINGUISHED FACULTY PRESENTERS
Jeffrey Dunn, PharmD, MBA
Senior Vice President
Chief Clinical Officer
VRx/MagellanRx
Carol Ann Huff, MD
Associate Professor of Oncology
Director, Myeloma Program
Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins Hospital
Edmund Pezalla, MD, MPH
CEO
Enlightenment Bioconsult
WHO SHOULD ATTEND?

This activity is designed to meet the educational needs of managed care pharmacy directors, clinical pharmacists, quality directors, medical directors, pharmacy directors, specialty pharmacists, quality directors, care managers, registered nurses, and other managed care and payer organization professionals.

STATEMENT OF NEED / PROGRAM OVERVIEW

The management of multiple myeloma (MM) is a priority area for MCOs in order to optimize clinically- and economically-appropriate care for their members. As novel agents become available, treatment decision making is becoming more complex and MCOs and other payer organizations need to appropriately and effectively design benefits that optimize both cost-efficiency and patient outcomes. Guidance is needed for the target audience to implement current guidelines, utilize clinical pathways, design appropriate medical and pharmacy benefits, and implement effective specialty pharmacy management services.

This interactive program is designed to engage the faculty and audience to develop solutions for managed care professionals to implement within their own setting to improve outcomes for patients with MM. Multidisciplinary faculty will be utilized featuring a managed care medical director, a pharmacy director, and a hematology/oncology expert.

EDUCATIONAL OBJECTIVES

At the conclusion of this activity, participants should be able to demonstrate improved ability to:
  • Evaluate recent clinical data affecting evidence-based treatment guidelines for MM
  • Demonstrate the value of clinical pathways initiatives as a means of reducing treatment variability and improving clinical and economic outcomes in the management of MM
  • Implement comprehensive care strategies involving effective communication methods
  • Integrate innovative oncology pharmacy benefit models with specialty pharmacy management services
AGENDA
Pre-Activity Learning Assessment and Opening Comments
Jeffrey Dunn, PharmD, MBA
The Expanding Treatment Armamentarium and Evolving Clinical and Supportive Care Guidelines
Carol Ann Huff, MD
Practical Strategies for the Implementation of Clinical Pathways
Edmund Pezalla, MD, MPH
Innovative Oncology Pharmacy Benefit Models and Specialty Pharmacy Management Services
Jeffrey Dunn, PharmD, MBA
Audience Question and Answer Session
Key Takeaways and Closing Comments
Post-activity Assessment and Evaluation
ACCREDITATION INFORMATION
Physician Continuing Medical Education
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and Impact Education, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education
Accreditation Statement
Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.


Credit Designation
Postgraduate Institute for Medicine designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number - 0809-9999-17-564-L01-P

Type of Activity: Knowledge

For Pharmacists: After receipt of a completed activity evaluation form you will be provided with instructions to have your credit immediately uploaded to CPE Monitor.

Continuing Nursing Education
Postgraduate Institute for Medicine is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This educational activity for 1.5 contact hours is provided by Postgraduate Institute for Medicine.

A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be emailed to you.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.

Hardware/Software Requirements
Compatible with Internet Explorer 6 and up, Mozilla Firefox 3 and up, Safari 4.0, and Google Chrome 10 and up.

Fee Information
There is no fee for this educational activity.

If you have any questions, please call (215) 619-8812 or email info@impactedu.net.

Register Now